Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verona Pharma plc

72.73
+0.47000.65%
Post-market: 72.730.00000.00%19:54 EDT
Volume:1.45M
Turnover:105.46M
Market Cap:6.19B
PE:-36.05
High:73.93
Open:72.74
Low:71.19
Close:72.26
Loading ...

Verona Pharma PLC (VRNA) Q4 2024 Earnings Call Highlights: Strong Launch of Ohtuvayre Amid ...

GuruFocus.com
·
28 Feb

Truist Securities Adjusts Verona Pharma Price Target to $76 From $57, Maintains Buy Rating

MT Newswires Live
·
28 Feb

Stock Track | Verona Pharma Soars 7.36% on Strong Ohtuvayre Sales and Positive Clinical Trial Progress

Stock Track
·
27 Feb

Verona Pharma PLC reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

Stock Track | Verona Pharma Soars 7.05% in Pre-Market on Strong Ohtuvayre Sales and Phase 2 Pipeline Progress

Stock Track
·
27 Feb

Verona Pharma Q4 Loss Widens

MT Newswires Live
·
27 Feb

Verona Pharma Q4 2024 GAAP EPADS $(0.40) Misses $(0.29) Estimate, Sales $36.64M Beat $33.05M Estimate

Benzinga
·
27 Feb

Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire
·
27 Feb

Verona Pharma PLC expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
25 Feb

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
25 Feb

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading

MT Newswires Live
·
19 Feb

Verona Pharma Announces March 2025 Investor Conference Participation

GlobeNewswire
·
18 Feb

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update

GlobeNewswire
·
13 Feb

Verona Pharma Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
12 Feb

What Makes Verona Pharma (VRNA) a Good Fit for 'Trend Investing'

Zacks
·
12 Feb

Verona Pharma price target raised to $72 from $44 at Canaccord

TIPRANKS
·
12 Feb

Verona Pharma Plc : Canaccord Genuity Raises Target Price to $72 From $44

THOMSON REUTERS
·
12 Feb

Piper Sandler Sticks to Their Buy Rating for Verona Pharma (VRNA)

TIPRANKS
·
05 Feb

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
05 Feb

European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading

MT Newswires Live
·
04 Feb